Literature DB >> 28469525

Recommendation of Repeated Ammonia Tests for Intrahepatic Portal-Systemic Shunt Without Cirrhosis in Elderly Patients With Psychiatric Symptoms.

Michiaki Abe1, Temma Soga1,2, Nobuya Obana3, Kazumasa Seiji4, Masao Tabata2, Natsumi Saito1, Ryutaro Arita1, Takehiro Numata1, Junichi Tanaka1, Hitoshi Kuroda1, Shin Takayama1, Yutaka Kagaya5, Tadashi Ishii1.   

Abstract

We report an elderly male patient with hyperammonemia induced by intrahepatic portal-systemic shunt without cirrhosis (IPSSwoC). The occasional emergence of his erratic behaviors was misdiagnosed as a psychiatric disorder. Regardless of his uneven symptoms, IPSSwoC was suspected due to his hyperammonemia. The contrast computed tomography of the abdomen revealed a congenital type of IPSSwoC. As blood ammonia levels are inconstant, repeated blood tests are recommended when this disease is suspected in elderly patients with psychiatric symptoms.

Entities:  

Keywords:  Portal-systemic shunt without cirrhosis; hyperammonemia; psychiatric symptoms

Year:  2017        PMID: 28469525      PMCID: PMC5398300          DOI: 10.1177/1179066017693597

Source DB:  PubMed          Journal:  Jpn Clin Med        ISSN: 1179-6707


Introduction

Portal-systemic encephalopathy (PSE) is frequently recognized by hyperammonemia in patients with portal-systemic shunt (PSS) due to chronic hepatitis and cirrhosis. It is very rarely seen in patients with congenital intrahepatic PSS without cirrhosis (IPSSwoC).[1] Many elderly patients with psychiatric symptoms frequently visit outpatient clinics of general medicine, but the diagnosis of IPSSwoC is often difficult to obtain because symptoms of PSE and hyperammonemia levels are inconstant.

Case

A 74-year-old man with behavior abnormalities (indoor urination and poriomania) was referred to our hospital for further examination. When the symptoms suddenly occurred before 1.5 months, head magnetic resonance imaging in some neighbor clinic ruled out brain lesions. A psychiatric disorder was suspected and quetiapine was prescribed, but his condition did not improve. After 2 weeks, an electroencephalogram was examined and showed general continuous slow wave patterns, and his blood test revealed hyperammonemia (218 µg/dL) in the previous clinic. Hepatic encephalopathy (HE) was suspected, but his psychiatric symptoms diminished spontaneously without any specific treatment by the time of his first visit to us. His consciousness was normal on examinations. His data showed just slight hyperammonemia (Table 1). He did not exhibit any neurological abnormal findings and any assertive symptoms associated with chronic hepatitis or cirrhosis, including flapping tremor, but his family quite a few times witnessed his behavior abnormalities. He had severe constipation and regularly used laxatives. At his second visit, he looked normal, but his venous ammonia level (135 µg/dL) was high again. Contrast computed tomography of the abdomen revealed a large right portal-middle hepatic venous shunt (Figure 1, striped arrows) and a left portal-left hepatic venous shunt (Figure 1, dotted arrows). He was diagnosed with IPSSwoC, type Ia on the Watanabe classification.[1] Considering his age and complications from the curative operation, conventional medical therapy was indicated. We advised him to take laxative and water for avoiding constipation and dehydration to prevent hyperammonemia. During 1.5 years of follow-up, he was well without any psychiatric symptoms.
Table 1.

Laboratory data at the first visit.

WBC5000/µL(4000–9000) ALP 417 U/L(115–359)Na143mEq/L(136–145)
RBC462×104/µL(4.27–5.70)γ-GTP13U/L(10–47)K3.9mEq/L(3.5–5.1)
Hb14.4g/dL(14.0–18.0)TP6.7g/dL(6.7–8.1)Cl108mEq/L(98–107)
Ht41.6%(40.0–52.0)Alb52.2%(54.6–66.1)Ca8.8mg/dL(8.6–10.1)
PLT16.4×104/µL(15.0–35.0)α13.8%(2.70–4.30) Ammonia 79 µg/dL(12.0–66.0)
CRP<0.1mg/dL(<0.3)α28.8%(6.20–10.50)PT1.07INR999.0–1.15)
T-Bil 2.7 mg/dL(0.2–1.0)β16.7%(5.00–7.50)T31.25ng/mL(0.70–1.76)
D-Bil0.3mg/dL(0.0–0.2)β25.9%(3.50–6.60)T410.5µg/dL(4.8–10.5)
AST27U/L(8–38)γ22.6%(12.3–22.8)TSH2.65µIU/mL(0.50–5.00)
ALT19U/L(4–43)BUN9mg/dL(8–20)HBsAg(−)
LDH200U/L(119–229)CRE0.60mg/dL(0.44–1.15)HBsAb(−)
ChE 201 U/L(217–491)CPK93U/L(62–287)HCV Ab0.4(0.00–0.90)

Note: Bold values are abnormal values. Ammonia 79 is significant and important, but T-Bil 2.7, ChE 201, ALP 417 are just slightly abnormal.

Abbreviations: α1, α1-globulin fraction; α2, α2-globulin fraction; β1, β1-globulin fraction; β2, β2-globulin fraction; γ, γ-globulin fraction; γ-GTP, γ-glutamyltranspeptidase; Alb, albumin fraction; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, asparatate aminotransferase; BUN, blood urea nitrogen; ChE, cholinesterase; CPK, creatine phosphorus kinase; CRE, creatinine; CRP, C-reactive protein; D-Bil, direct bilirubin; Hb, hemoglobin; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; Ht, hematocrit; LDH, lactate dehydrogenase; PLT, platelet; PT, prothrombin time; RBC, red blood cell; T3, triiodothyronine; T4, thyroxin; T-Bil, total bilirubin; TP, total protein; TSH, thyroid-stimulating hormone; WBC, white blood cell.

Figure 1.

Contrast computed tomography of the abdomen. Striped arrows: a large right portal-middle hepatic venous shunt. Dotted arrows: a left portal-left hepatic venous shunt.

Laboratory data at the first visit. Note: Bold values are abnormal values. Ammonia 79 is significant and important, but T-Bil 2.7, ChE 201, ALP 417 are just slightly abnormal. Abbreviations: α1, α1-globulin fraction; α2, α2-globulin fraction; β1, β1-globulin fraction; β2, β2-globulin fraction; γ, γ-globulin fraction; γ-GTP, γ-glutamyltranspeptidase; Alb, albumin fraction; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, asparatate aminotransferase; BUN, blood urea nitrogen; ChE, cholinesterase; CPK, creatine phosphorus kinase; CRE, creatinine; CRP, C-reactive protein; D-Bil, direct bilirubin; Hb, hemoglobin; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; Ht, hematocrit; LDH, lactate dehydrogenase; PLT, platelet; PT, prothrombin time; RBC, red blood cell; T3, triiodothyronine; T4, thyroxin; T-Bil, total bilirubin; TP, total protein; TSH, thyroid-stimulating hormone; WBC, white blood cell. Contrast computed tomography of the abdomen. Striped arrows: a large right portal-middle hepatic venous shunt. Dotted arrows: a left portal-left hepatic venous shunt.

Discussion

Congenital IPSSwoC is very rare and easily misdiagnosed as psychiatric disorders because both symptoms resemble each other. This case was type B of HE according to International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) practice guidelines.[2] We did not examine blood citrulline in the present case, but type D of HE (urea-cycle disorders) could be ruled out because of elder age and clinical finding.[3] Precipitating factors of HE (eg, excess protein, infection, diuretics, hyponatremia, acidosis, gastrointestinal bleeding, trauma, sedatives) worsen the relevant components (hyperammonemia, hyponatremia, inflammatory cytokines, benzodiazepines) and oxidative stress–derived brain damages.[4] Hyperammonemia is an important diagnostic clue to diagnose acute liver dysfunction; however, blood ammonia level does not always correlate with degrees of PSE in chronic liver disease.[5] Encephalopathy from IPSSwoC intermittently occurs in the elderly, probably because of the irregular susceptibility of the brain to ammonia by aging.[6,7] To understand the correlation between blood ammonia levels and the PSE, we extracted Japanese congenital or idiopathic PSS without cirrhosis cases from the National Center for Biotechnology Information literature search sites[3,8-20] and estimated grades of PSE based on the symptoms described in them according to the guideline[21] (Table 2). There was a moderate correlation between blood ammonia levels and the estimated grades of PSE of PSS without cirrhosis (Figure 2, r2 = 0.495).
Table 2.

Fourteen cases of Japanese PSE by PSS without cirrhosis.

AgeSexBlood ammonia[a], µg/dLAsterixisEstimated grade of PSE[21]Ref. No.
67Female84+112
60Male100+114
60Female131+211
66Female141+216
66Male170120
75Male184[a]415
73Female18719
69Female21023
72Female211+418
49Female217+313
74Male2182This study
69Female228+310
63Male273N/A219
80Female300[a]+38
37Female317417

Abbreviations: N/A, not applicable; PSE, portal-systemic encephalopathy; PSS, portal-systemic shunt.

These 2 values reported in the papers were confirmed unit errors by personal communications.

Figure 2.

The correlation chart between blood ammonia levels and estimated grades of portal-systemic encephalopathy of portal-systemic shunt without cirrhosis.

Fourteen cases of Japanese PSE by PSS without cirrhosis. Abbreviations: N/A, not applicable; PSE, portal-systemic encephalopathy; PSS, portal-systemic shunt. These 2 values reported in the papers were confirmed unit errors by personal communications. The correlation chart between blood ammonia levels and estimated grades of portal-systemic encephalopathy of portal-systemic shunt without cirrhosis. We should note that repeated ammonia blood tests are important for the diagnosis of IPSSwoC in elderly patients when they present psychiatric symptoms because blood ammonia level could be changeable according to daily activity and because of the factors of hyperammonemia. Limitation is that the grade of PSE was estimated only through the information described in each paper. It is necessary to accumulate and evaluate IPSSwoC data prospectively. And it is important to investigate how many blood ammonia tests are needed to not overlook IPSSwoC.
  21 in total

Review 1.  An inferior mesenteric-caval shunt via the internal iliac vein with portosystemic encephalopathy.

Authors:  M Otake; Y Kobayashi; D Hashimoto; T Igarashi; M Takahashi; H Kumaoka; M Takagi; K Kawamura; S Koide; Y Sasada; F Kageyama; T Kawasaki; H Nakamura
Journal:  Intern Med       Date:  2001-09       Impact factor: 1.271

2.  PORTAL-SYSTEMIC ENCEPHALOPATHY DUE TO CONGENITAL INTRAHEPATIC SHUNTS.

Authors:  N H RASKIN; J B PRICE; R A FISHMAN
Journal:  N Engl J Med       Date:  1964-01-30       Impact factor: 91.245

3.  Serum ammonia level for the evaluation of hepatic encephalopathy.

Authors:  Phillip S Ge; Bruce A Runyon
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

Review 4.  Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment.

Authors:  A Watanabe
Journal:  J Gastroenterol Hepatol       Date:  2000-09       Impact factor: 4.029

5.  Portosystemic Encephalopathy without Liver Cirrhosis Masquerading as Depression.

Authors:  Takanori Asakura; Nobutake Ito; Takahiro Sohma; Nobuaki Mori
Journal:  Intern Med       Date:  2015-07-01       Impact factor: 1.271

Review 6.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Case report: portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt.

Authors:  M Kiriyama; S Takashima; H Sahara; Y Kurosaka; M Matsushita; T Akiyama; F Tomita; H Saito; T Kosaka; I Kita; Y Kojima; S Takegawa
Journal:  J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 4.029

8.  Successful treatment using coil embolization of a symptomatic intrahepatic portosystemic venous shunt developing through a patent ductus venosus in a noncirrhotic adult.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Kenji Momose; Hirotaka Hirano; Masaru Yoshida; Takeshi Azuma
Journal:  Intern Med       Date:  2013-03-01       Impact factor: 1.271

Review 9.  Pathogenetic mechanisms of hepatic encephalopathy.

Authors:  D Häussinger; F Schliess
Journal:  Gut       Date:  2008-08       Impact factor: 23.059

10.  Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report.

Authors:  Yasuaki Furue; Hisashi Hidaka; Kaoru Fujii; Keiji Matsunaga; Wasaburo Koizumi
Journal:  J Med Case Rep       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.